Ashlee Fischer
Optometrist · Gillette, WYNPI 1710212378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Alcon at 52.0% of the total. Reporting peaked in 2023 at $263 and has fallen 68.1% since, to $84 in 2025.
Across 41 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$511
- LKC Technologies, Inc.$120
- AbbVie$109
- Coopervision Inc.$78
- Bausch & Lomb Americas Inc.$53
- Carl Zeiss Meditec, Inc.$49
- plus $64 from 3 others
What the payments were for
- Food & beverage$984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 27 | $511 |
| LKC Technologies, Inc. | 2 | $120 |
| AbbVie(2 entities) | 3 | $109 |
| Coopervision Inc. | 2 | $78 |
| Bausch & Lomb Americas Inc. | 3 | $53 |
| Carl Zeiss Meditec, Inc. | 1 | $49 |
| ABB Con-cise Optical Group LLC | 1 | $26 |
| Harrow Eye, LLC | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $17 |
How this compares
$984 in reported general payments places this provider in the 80th percentile of 102 optometrist providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $3,129 |
| ValacyclovirValacyclovir Hcl | 18 | $550 |
| Latanoprost | 44 | $280 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $222 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Gillette
- Joseph FischerGillette$918
- Melissa YoungerGillette$652
- Robert MillsGillette$279
- Mark WellsCheyenne$251K
- David EldredCheyenne$177K
- Joseph MunsellCheyenne$5K
- Jason WhitmanCasper$4K
- Michelle ChaneyLaramie$4K
- Shelby ZemskiCheyenne$3K
- David BisbeeCheyenne$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.